Search

everythinglearnresearchcommunity

for

Search:↓

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Young smokers with conditions like hypertension and diabetes are at higher risk for early coronary artery disease.

Ischemia-modified albumin is not effective for diagnosing stable angina compared to exercise stress tests.

The 2003 Australian Medicines Handbook was a clear, concise drug reference guide, updated with new topics and evidence, and considered essential for medical practice.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Age, gender, obesity, and smoking increase the risk of severe COVID-19.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

A man developed heart problems after using a baldness treatment for 4 months, suggesting that people with heart issues should avoid this treatment.

Women with irregular periods have a higher risk of heart disease.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

Premature hair loss doesn't increase the risk of metabolic syndrome.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Early diagnosis, innovative treatments, and considering systemic conditions are crucial in dermatological care.

77% of recovered COVID-19 patients in Nepal experienced long-term symptoms like fatigue, hair loss, and breathing issues.

Long COVID causes various long-term health issues and needs better awareness and treatment.

Middle-aged women with dilated cardiomyopathy should be screened for antiphospholipid syndrome.

A man with a rare lung-focused form of hypereosinophilic syndrome improved with steroid treatment.

MIS-A is a severe complication after COVID-19, mostly in young black males, needing more research and awareness.

Post-COVID syndrome causes long-lasting symptoms like fatigue, breathing issues, and anxiety.

Young Indians with coronary artery disease often have risk factors like smoking and central obesity, and cutaneous markers should be monitored for lifestyle changes.

Metabolic syndrome is common in African populations, needing urgent prevention and treatment.

Premature graying of hair may suggest health issues and currently lacks effective treatments.

More research is needed to understand how testosterone is maintained in adult males.

Kawasaki Disease is rare and often missed in adults, who show different symptoms than children, and may benefit from early treatment.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Early treatment with immunoglobulin and aspirin reduces heart complications in children with Kawasaki disease.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.